{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:19:21Z","timestamp":1791314361422,"version":"4.3.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/gt.2011.170","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T12:27:21Z","timestamp":1323347241000},"page":"1139-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Using non-coding small RNAs to develop therapies for Huntington's disease"],"prefix":"10.1038","volume":"18","author":[{"given":"Y","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R M","family":"Friedlander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,8]]},"reference":[{"key":"BFgt2011170_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971\u2013983.","journal-title":"Cell"},{"key":"BFgt2011170_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1001\/archneurol.2009.180","volume":"66","author":"SQ Harper","year":"2009","unstructured":"Harper SQ . Progress and challenges in RNA interference therapy for Huntington disease. Arch Neurol 2009; 66: 933\u2013938.","journal-title":"Arch Neurol"},{"key":"BFgt2011170_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.gt.3302664","volume":"13","author":"EM Denovan-Wright","year":"2006","unstructured":"Denovan-Wright EM, Davidson BL . RNAi: a potential therapy for the dominantly inherited nucleotide repeat diseases. Gene Therapy 2006; 13: 525\u2013531.","journal-title":"Gene Therapy"},{"key":"BFgt2011170_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0070-2153(06)75003-7","volume":"75","author":"RL Boudreau","year":"2006","unstructured":"Boudreau RL, Davidson BL . RNAi therapy for neurodegenerative diseases. Curr Top Dev Biol 2006; 75: 73\u201392.","journal-title":"Curr Top Dev Biol"},{"key":"BFgt2011170_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","volume":"53","author":"YL Wang","year":"2005","unstructured":"Wang YL, Liu W, Wada E, Murata M, Wada K, Kanazawa I . Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA. Neurosci Res 2005; 53: 241\u2013249.","journal-title":"Neurosci Res"},{"key":"BFgt2011170_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/mt.2008.50","volume":"16","author":"NR Franich","year":"2008","unstructured":"Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D . AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease. Mol Ther 2008; 16: 947\u2013956.","journal-title":"Mol Ther"},{"key":"BFgt2011170_CR7","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL, Boudreau RL, Harper SQ, Staber PD, Monteys AM, Martins I et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 2008; 105: 5868\u20135873.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2011170_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ et al. Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice. Mol Ther 2009; 17: 1053\u20131063.","journal-title":"Mol Ther"},{"key":"BFgt2011170_CR9","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M et al. Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci USA 2007; 104: 17204\u201317209.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2011170_CR10","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","volume":"12","author":"E Rodriguez-Lebron","year":"2005","unstructured":"Rodriguez-Lebron E, Denovan-Wright EM, Nash K, Lewin AS, Mandel RJ . Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice. Mol Ther 2005; 12: 618\u2013633.","journal-title":"Mol Ther"},{"key":"BFgt2011170_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.nbd.2007.11.003","volume":"29","author":"EM Denovan-Wright","year":"2008","unstructured":"Denovan-Wright EM, Rodriguez-Lebron E, Lewin AS, Mandel RJ . Unexpected off-targeting effects of anti-huntingtin ribozymes and siRNA in vivo. Neurobiol Dis 2008; 29: 446\u2013455.","journal-title":"Neurobiol Dis"},{"key":"BFgt2011170_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bbrc.2006.02.141","volume":"343","author":"Y Machida","year":"2006","unstructured":"Machida Y, Okada T, Kurosawa M, Oyama F, Ozawa K, Nukina N . rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse. Biochem Biophys Res Commun 2006; 343: 190\u2013197.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt2011170_CR13","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S et al. Sustained effects of nonallele-specific Huntingtin silencing. Ann Neurol 2009; 65: 276\u2013285.","journal-title":"Ann Neurol"},{"key":"BFgt2011170_CR14","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/hum.2006.160","volume":"18","author":"B Huang","year":"2007","unstructured":"Huang B, Schiefer J, Sass C, Landwehrmeyer GB, Kosinski CM, Kochanek S . High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo. Hum Gene Ther 2007; 18: 303\u2013311.","journal-title":"Hum Gene Ther"},{"key":"BFgt2011170_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-642-12168-5_6","volume-title":"RNA Technologies and Their Applications","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Friedlander RM . Silencing Huntington's disease (HD) gene with RNAi. In: Erdmann VA and Barciszewski J (eds). RNA Technologies and Their Applications. Springer: Berlin, 2010, pp 131\u2013160."},{"key":"BFgt2011170_CR16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1089\/hum.2007.116","volume":"19","author":"PH van Bilsen","year":"2008","unstructured":"van Bilsen PH, Jaspers L, Lombardi MS, Odekerken JC, Burright EN, Kaemmerer WF . Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts. Hum Gene Ther 2008; 19: 710\u2013719.","journal-title":"Hum Gene Ther"},{"key":"BFgt2011170_CR17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","volume":"108","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Engelman J, Friedlander RM . Allele-specific silencing of mutant Huntington's disease gene. J Neurochem 2009; 108: 82\u201390.","journal-title":"J Neurochem"},{"key":"BFgt2011170_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1749-6632.2009.04975.x","volume":"1175","author":"J Hu","year":"2009","unstructured":"Hu J, Matsui M, Corey DR . Allele-selective inhibition of mutant huntingtin by peptide nucleic acid-peptide conjugates, locked nucleic acid, and small interfering RNA. Ann NY Acad Sci 2009; 1175: 24\u201331.","journal-title":"Ann NY Acad Sci"},{"key":"BFgt2011170_CR19","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/nmeth.1261","volume":"5","author":"W Liu","year":"2008","unstructured":"Liu W, Kennington LA, Rosas HD, Hersch S, Cha JH, Zamore PD et al. Linking SNPs to CAG repeat length in Huntington's disease patients. Nat Methods 2008; 5: 951\u2013953.","journal-title":"Nat Methods"},{"key":"BFgt2011170_CR20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","volume":"15","author":"S Palfi","year":"2007","unstructured":"Palfi S, Brouillet E, Jarraya B, Bloch J, Jan C, Shin M et al. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates. Mol Ther 2007; 15: 1444\u20131451.","journal-title":"Mol Ther"},{"key":"BFgt2011170_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","volume":"217","author":"MS Lombardi","year":"2009","unstructured":"Lombardi MS, Jaspers L, Spronkmans C, Gellera C, Taroni F, Di Maria E et al. A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference. Exp Neurol 2009; 217: 312\u2013319.","journal-title":"Exp Neurol"},{"key":"BFgt2011170_CR22","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/nar\/gkq1323","volume":"39","author":"M de Mezer","year":"2011","unstructured":"de Mezer M, Wojciechowska M, Napierala M, Sobczak K, Krzyzosiak WJ . Mutant CAG repeats of huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res 2011; 39: 3852\u20133863.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.1539","volume":"27","author":"J Hu","year":"2009","unstructured":"Hu J, Matsui M, Gagnon KT, Schwartz JC, Gabillet S, Arar K et al. Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs. Nat Biotechnol 2009; 27: 478\u2013484.","journal-title":"Nat Biotechnol"},{"key":"BFgt2011170_CR24","doi-asserted-by":"publisher","first-page":"10166","DOI":"10.1021\/bi101208k","volume":"49","author":"KT Gagnon","year":"2010","unstructured":"Gagnon KT, Pendergraff HM, Deleavey GF, Swayze EE, Potier P, Randolph J et al. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. Biochemistry 2010; 49: 10166\u201310178.","journal-title":"Biochemistry"},{"key":"BFgt2011170_CR25","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","volume":"17","author":"J Hu","year":"2010","unstructured":"Hu J, Liu J, Corey DR . Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism. Chem Biol 2010; 17: 1183\u20131188.","journal-title":"Chem Biol"},{"key":"BFgt2011170_CR26","doi-asserted-by":"publisher","first-page":"5578","DOI":"10.1093\/nar\/gkr156","volume":"39","author":"A Fiszer","year":"2011","unstructured":"Fiszer A, Mykowska A, Krzyzosiak WJ . Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats. Nucleic Acids Res 2011; 39: 5578\u20135585.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR27","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q et al. RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model. Proc Natl Acad Sci USA 2005; 102: 5820\u20135825.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2011170_CR28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH, Jinnah HA, Duan K, Kotzuk JA et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum Mol Genet 1999; 8: 397\u2013407.","journal-title":"Hum Mol Genet"},{"key":"BFgt2011170_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","volume":"87","author":"L Mangiarini","year":"1996","unstructured":"Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493\u2013506.","journal-title":"Cell"},{"key":"BFgt2011170_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2005.03035.x","volume":"93","author":"S Kotliarova","year":"2005","unstructured":"Kotliarova S, Jana NR, Sakamoto N, Kurosawa M, Miyazaki H, Nekooki M et al. Decreased expression of hypothalamic neuropeptides in Huntington disease transgenic mice with expanded polyglutamine-EGFP fluorescent aggregates. J Neurochem 2005; 93: 641\u2013653.","journal-title":"J Neurochem"},{"key":"BFgt2011170_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1523\/JNEUROSCI.20-01-00219.2000","volume":"20","author":"MC Senut","year":"2000","unstructured":"Senut MC, Suhr ST, Kaspar B, Gage FH . Intraneuronal aggregate formation and cell death after viral expression of expanded polyglutamine tracts in the adult rat brain. J Neurosci 2000; 20: 219\u2013229.","journal-title":"J Neurosci"},{"key":"BFgt2011170_CR32","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1523\/JNEUROSCI.22-09-03473.2002","volume":"22","author":"LP de Almeida","year":"2002","unstructured":"de Almeida LP, Ross CA, Zala D, Aebischer P, Deglon N . Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci 2002; 22: 3473\u20133483.","journal-title":"J Neurosci"},{"key":"BFgt2011170_CR33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","volume":"12","author":"EJ Slow","year":"2003","unstructured":"Slow EJ, van Raamsdonk J, Rogers D, Coleman SH, Graham RK, Deng Y et al. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease. Hum Mol Genet 2003; 12: 1555\u20131567.","journal-title":"Hum Mol Genet"},{"key":"BFgt2011170_CR34","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","volume":"28","author":"M Gray","year":"2008","unstructured":"Gray M, Shirasaki DI, Cepeda C, Andre VM, Wilburn B, Lu XH et al. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice. J Neurosci 2008; 28: 6182\u20136195.","journal-title":"J Neurosci"},{"key":"BFgt2011170_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","volume":"157","author":"J Spampanato","year":"2008","unstructured":"Spampanato J, Gu X, Yang XW, Mody I . Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease. Neuroscience 2008; 157: 606\u2013620.","journal-title":"Neuroscience"},{"key":"BFgt2011170_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA, Leavitt BR, LePiane F, Singaraja R et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 1999; 23: 181\u2013192.","journal-title":"Neuron"},{"key":"BFgt2011170_CR37","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1371\/journal.pgen.0020140","volume":"2","author":"DS Schwarz","year":"2006","unstructured":"Schwarz DS, Ding H, Kennington L, Moore JT, Schelter J, Burchard J et al. Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2006; 2: e140.","journal-title":"PLoS Genet"},{"key":"BFgt2011170_CR38","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ajhg.2009.02.003","volume":"84","author":"SC Warby","year":"2009","unstructured":"Warby SC, Montpetit A, Hayden AR, Carroll JB, Butland SL, Visscher H et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009; 84: 351\u2013366.","journal-title":"Am J Hum Genet"},{"key":"BFgt2011170_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF02257483","volume":"20","author":"CM Ambrose","year":"1994","unstructured":"Ambrose CM, Duyao MP, Barnes G, Bates GP, Lin CS, Srinidhi J et al. Structure and expression of the Huntington's disease gene: evidence against simple inactivation due to an expanded CAG repeat. Somat Cell Mol Genet 1994; 20: 27\u201338.","journal-title":"Somat Cell Mol Genet"},{"key":"BFgt2011170_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/hmg\/4.2.207","volume":"4","author":"E Almqvist","year":"1995","unstructured":"Almqvist E, Spence N, Nichol K, Andrew SE, Vesa J, Peltonen L et al. Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease. Hum Mol Genet 1995; 4: 207\u2013214.","journal-title":"Hum Mol Genet"},{"key":"BFgt2011170_CR41","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/hmg\/4.2.203","volume":"4","author":"DC Rubinsztein","year":"1995","unstructured":"Rubinsztein DC, Leggo J, Goodburn S, Barton DE, Ferguson-Smith MA . Haplotype analysis of the delta 2642 and (CAG)n polymorphisms in the Huntington's disease (HD) gene provides an explanation for an apparent \u2018founder\u2019 HD haplotype. Hum Mol Genet 1995; 4: 203\u2013206.","journal-title":"Hum Mol Genet"},{"key":"BFgt2011170_CR42","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1093\/hmg\/3.7.1129","volume":"3","author":"A Novelletto","year":"1994","unstructured":"Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, Ajmar F et al. Polymorphism analysis of the huntingtin gene in Italian families affected with Huntington disease. Hum Mol Genet 1994; 3: 1129\u20131132.","journal-title":"Hum Mol Genet"},{"key":"BFgt2011170_CR43","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1136\/jnnp.64.6.758","volume":"64","author":"I Vuillaume","year":"1998","unstructured":"Vuillaume I, Vermersch P, Destee A, Petit H, Sablonniere B . Genetic polymorphisms adjacent to the CAG repeat influence clinical features at onset in Huntington's disease. J Neurol Neurosurg Psychiatry 1998; 64: 758\u2013762.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFgt2011170_CR44","doi-asserted-by":"publisher","first-page":"5469","DOI":"10.1093\/nar\/gkg766","volume":"31","author":"K Sobczak","year":"2003","unstructured":"Sobczak K, de Mezer M, Michlewski G, Krol J, Krzyzosiak WJ . RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res 2003; 31: 5469\u20135482.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR45","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/0092-8674(95)90074-8","volume":"81","author":"AM Gacy","year":"1995","unstructured":"Gacy AM, Goellner G, Juranic N, Macura S, McMurray CT . Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell 1995; 81: 533\u2013540.","journal-title":"Cell"},{"key":"BFgt2011170_CR46","doi-asserted-by":"publisher","first-page":"10873","DOI":"10.1021\/bi0502339","volume":"44","author":"M Broda","year":"2005","unstructured":"Broda M, Kierzek E, Gdaniec Z, Kulinski T, Kierzek R . Thermodynamic stability of RNA structures formed by CNG trinucleotide repeats. Implication for prediction of RNA structure. Biochemistry 2005; 44: 10873\u201310882.","journal-title":"Biochemistry"},{"key":"BFgt2011170_CR47","doi-asserted-by":"publisher","first-page":"12755","DOI":"10.1074\/jbc.M109.078790","volume":"285","author":"K Sobczak","year":"2010","unstructured":"Sobczak K, Michlewski G, de Mezer M, Kierzek E, Krol J, Olejniczak M et al. Structural diversity of triplet repeat RNAs. J Biol Chem 2010; 285: 12755\u201312764.","journal-title":"J Biol Chem"},{"key":"BFgt2011170_CR48","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jmb.2004.05.021","volume":"340","author":"G Michlewski","year":"2004","unstructured":"Michlewski G, Krzyzosiak WJ . Molecular architecture of CAG repeats in human disease related transcripts. J Mol Biol 2004; 340: 665\u2013679.","journal-title":"J Mol Biol"},{"key":"BFgt2011170_CR49","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.molcel.2007.01.031","volume":"25","author":"J Krol","year":"2007","unstructured":"Krol J, Fiszer A, Mykowska A, Sobczak K, de Mezer M, Krzyzosiak WJ . Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 2007; 25: 575\u2013586.","journal-title":"Mol Cell"},{"key":"BFgt2011170_CR50","doi-asserted-by":"publisher","first-page":"31079","DOI":"10.1074\/jbc.272.49.31079","volume":"272","author":"M Napierala","year":"1997","unstructured":"Napierala M, Krzyzosiak WJ . CUG repeats present in myotonin kinase RNA form metastable \"slippery\" hairpins. J Biol Chem 1997; 272: 31079\u201331085.","journal-title":"J Biol Chem"},{"key":"BFgt2011170_CR51","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1093\/nar\/gkf651","volume":"30","author":"DA Braasch","year":"2002","unstructured":"Braasch DA, Liu Y, Corey DR . Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Nucleic Acids Res 2002; 30: 5160\u20135167.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR52","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1006\/jmbi.1999.3277","volume":"294","author":"N Dias","year":"1999","unstructured":"Dias N, Dheur S, Nielsen PE, Gryaznov S, Van Aerschot A, Herdewijn P et al. Antisense PNA tridecamers targeted to the coding region of Ha-ras mRNA arrest polypeptide chain elongation. J Mol Biol 1999; 294: 403\u2013416.","journal-title":"J Mol Biol"},{"key":"BFgt2011170_CR53","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nbt831","volume":"21","author":"AL Jackson","year":"2003","unstructured":"Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M et al. Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 2003; 21: 635\u2013637.","journal-title":"Nat Biotechnol"},{"key":"BFgt2011170_CR54","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/nar\/gki324","volume":"33","author":"S Qiu","year":"2005","unstructured":"Qiu S, Adema CM, Lane T . A computational study of off-target effects of RNA interference. Nucleic Acids Res 2005; 33: 1834\u20131847.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR55","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1093\/nar\/gki762","volume":"33","author":"X Lin","year":"2005","unstructured":"Lin X, Ruan X, Anderson MG, McDowell JA, Kroeger PE, Fesik SW et al. siRNA-mediated off-target gene silencing triggered by a 7 nt complementation. Nucleic Acids Res 2005; 33: 4527\u20134535.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR56","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1261\/rna.25706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, Burchard J, Schelter J, Chau BN, Cleary M, Lim L et al. Widespread siRNA \u201coff-target\u201d transcript silencing mediated by seed region sequence complementarity. RNA 2006; 12: 1179\u20131187.","journal-title":"RNA"},{"key":"BFgt2011170_CR57","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nmeth854","volume":"3","author":"A Birmingham","year":"2006","unstructured":"Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y et al. 3\u2032 UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 2006; 3: 199\u2013204.","journal-title":"Nat Methods"},{"key":"BFgt2011170_CR58","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1101\/gad.1184404","volume":"18","author":"JG Doench","year":"2004","unstructured":"Doench JG, Sharp PA . Specificity of microRNA target selection in translational repression. Genes Dev 2004; 18: 504\u2013511.","journal-title":"Genes Dev"},{"key":"BFgt2011170_CR59","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nsmb780","volume":"11","author":"B Haley","year":"2004","unstructured":"Haley B, Zamore PD . Kinetic analysis of the RNAi enzyme complex. Nat Struct Mol Biol 2004; 11: 599\u2013606.","journal-title":"Nat Struct Mol Biol"},{"key":"BFgt2011170_CR60","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0092-8674(03)00759-1","volume":"115","author":"DS Schwarz","year":"2003","unstructured":"Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD . Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199\u2013208.","journal-title":"Cell"},{"key":"BFgt2011170_CR61","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","volume":"115","author":"A Khvorova","year":"2003","unstructured":"Khvorova A, Reynolds A, Jayasena SD . Functional siRNAs and miRNAs exhibit strand bias. Cell 2003; 115: 209\u2013216.","journal-title":"Cell"},{"key":"BFgt2011170_CR62","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/nbt936","volume":"22","author":"A Reynolds","year":"2004","unstructured":"Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A . Rational siRNA design for RNA interference. Nat Biotechnol 2004; 22: 326\u2013330.","journal-title":"Nat Biotechnol"},{"key":"BFgt2011170_CR63","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","volume":"27","author":"A Grimson","year":"2007","unstructured":"Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP . MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007; 27: 91\u2013105.","journal-title":"Mol Cell"},{"key":"BFgt2011170_CR64","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","volume":"10","author":"C Burger","year":"2004","unstructured":"Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther 2004; 10: 302\u2013317.","journal-title":"Mol Ther"},{"key":"BFgt2011170_CR65","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1128\/JVI.78.13.6808-6817.2004","volume":"78","author":"JC Paterna","year":"2004","unstructured":"Paterna JC, Feldon J, Bueler H . Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol 2004; 78: 6808\u20136817.","journal-title":"J Virol"},{"key":"BFgt2011170_CR66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/hum.2006.178","volume":"18","author":"JM Taymans","year":"2007","unstructured":"Taymans JM, Vandenberghe LH, Haute CV, Thiry I, Deroose CM, Mortelmans L et al. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther 2007; 18: 195\u2013206.","journal-title":"Hum Gene Ther"},{"key":"BFgt2011170_CR67","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1073\/pnas.97.7.3428","volume":"97","author":"BL Davidson","year":"2000","unstructured":"Davidson BL, Stein CS, Heth JA, Martins I, Kotin RM, Derksen TA et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428\u20133432.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFgt2011170_CR68","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nature04791","volume":"441","author":"D Grimm","year":"2006","unstructured":"Grimm D, Streetz KL, Jopling CL, Storm TA, Pandey K, Davis CR et al. Fatality in mice due to oversaturation of cellular microRNA\/short hairpin RNA pathways. Nature 2006; 441: 537\u2013541.","journal-title":"Nature"},{"key":"BFgt2011170_CR69","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nchembio839","volume":"2","author":"D Bumcrot","year":"2006","unstructured":"Bumcrot D, Manoharan M, Koteliansky V, Sah DW . RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol 2006; 2: 711\u2013719.","journal-title":"Nat Chem Biol"},{"key":"BFgt2011170_CR70","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1021\/jm049167j","volume":"48","author":"CR Allerson","year":"2005","unstructured":"Allerson CR, Sioufi N, Jarres R, Prakash TP, Naik N, Berdeja A et al. Fully 2\u2032-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 2005; 48: 901\u2013904.","journal-title":"J Med Chem"},{"key":"BFgt2011170_CR71","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1093\/nar\/gkh705","volume":"32","author":"S Hoshika","year":"2004","unstructured":"Hoshika S, Minakawa N, Matsuda A . Synthesis and physical and physiological properties of 4\u2032-thioRNA: application to post-modification of RNA aptamer toward NF-kappaB. Nucleic Acids Res 2004; 32: 3815\u20133825.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR72","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1021\/jm050822c","volume":"49","author":"P Dande","year":"2006","unstructured":"Dande P, Prakash TP, Sioufi N, Gaus H, Jarres R, Berdeja A et al. Improving RNA interference in mammalian cells by 4\u2032-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2\u2032-O-alkyl modifications. J Med Chem 2006; 49: 1624\u20131634.","journal-title":"J Med Chem"},{"key":"BFgt2011170_CR73","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/nar\/gkg393","volume":"31","author":"F Czauderna","year":"2003","unstructured":"Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ et al. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 2003; 31: 2705\u20132716.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR74","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1261\/rna.30706","volume":"12","author":"AL Jackson","year":"2006","unstructured":"Jackson AL, Burchard J, Leake D, Reynolds A, Schelter J, Guo J et al. Position-specific chemical modification of siRNAs reduces \u201coff-target\u201d transcript silencing. RNA 2006; 12: 1197\u20131205.","journal-title":"RNA"},{"key":"BFgt2011170_CR75","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/nar\/gkg147","volume":"31","author":"M Amarzguioui","year":"2003","unstructured":"Amarzguioui M, Holen T, Babaie E, Prydz H . Tolerance for mutations and chemical modifications in a siRNA. Nucleic Acids Res 2003; 31: 589\u2013595.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR76","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1261\/rna.2252206","volume":"12","author":"L Tonges","year":"2006","unstructured":"Tonges L, Lingor P, Egle R, Dietz GP, Fahr A, Bahr M . Stearylated octaarginine and artificial virus-like particles for transfection of siRNA into primary rat neurons. RNA 2006; 12: 1431\u20131438.","journal-title":"RNA"},{"key":"BFgt2011170_CR77","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1021\/bc015508l","volume":"12","author":"S Futaki","year":"2001","unstructured":"Futaki S, Ohashi W, Suzuki T, Niwa M, Tanaka S, Ueda K et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 2001; 12: 1005\u20131011.","journal-title":"Bioconjug Chem"},{"key":"BFgt2011170_CR78","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1042\/BST0350044","volume":"35","author":"L Crombez","year":"2007","unstructured":"Crombez L, Charnet A, Morris MC, Aldrian-Herrada G, Heitz F, Divita G . A non-covalent peptide-based strategy for siRNA delivery. Biochem Soc Trans 2007; 35: 44\u201346.","journal-title":"Biochem Soc Trans"},{"key":"BFgt2011170_CR79","first-page":"251","volume":"309","author":"F Simeoni","year":"2005","unstructured":"Simeoni F, Morris MC, Heitz F, Divita G . Peptide-based strategy for siRNA delivery into mammalian cells. Methods Mol Biol 2005; 309: 251\u2013260.","journal-title":"Methods Mol Biol"},{"key":"BFgt2011170_CR80","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1093\/nar\/gkl388","volume":"34","author":"TC Chu","year":"2006","unstructured":"Chu TC, Twu KY, Ellington AD, Levy M . Aptamer mediated siRNA delivery. Nucleic Acids Res 2006; 34: e73.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2011170_CR81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature05901","volume":"448","author":"P Kumar","year":"2007","unstructured":"Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007; 448: 39\u201343.","journal-title":"Nature"},{"key":"BFgt2011170_CR82","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.brainres.2008.12.032","volume":"1256","author":"MP Jankowski","year":"2009","unstructured":"Jankowski MP, McIlwrath SL, Jing X, Cornuet PK, Salerno KM, Koerber HR et al. Sox11 transcription factor modulates peripheral nerve regeneration in adult mice. Brain Res 2009; 1256: 43\u201354.","journal-title":"Brain Res"},{"key":"BFgt2011170_CR83","doi-asserted-by":"publisher","first-page":"10040","DOI":"10.1523\/JNEUROSCI.3643-04.2004","volume":"24","author":"TJ Davidson","year":"2004","unstructured":"Davidson TJ, Harel S, Arboleda VA, Prunell GF, Shelanski ML, Greene LA et al. Highly efficient small interfering RNA delivery to primary mammalian neurons induces MicroRNA-like effects before mRNA degradation. J Neurosci 2004; 24: 10040\u201310046.","journal-title":"J Neurosci"},{"key":"BFgt2011170_CR84","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0014-5793(03)01505-9","volume":"558","author":"A Muratovska","year":"2004","unstructured":"Muratovska A, Eccles MR . Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett 2004; 558: 63\u201368.","journal-title":"FEBS Lett"},{"key":"BFgt2011170_CR85","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2741\/3245","volume":"14","author":"EI Schwartz","year":"2009","unstructured":"Schwartz EI . Potential application of RNAi for understanding and therapy of neurodegenerative diseases. Front Biosci 2009; 14: 297\u2013320.","journal-title":"Front Biosci"},{"key":"BFgt2011170_CR86","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00439-011-0995-8","volume":"130","author":"AA Seyhan","year":"2011","unstructured":"Seyhan AA . RNAi: a potential new class of therapeutic for human genetic disease. Hum Genet 2011; 130: 583\u2013605.","journal-title":"Hum Genet"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2011170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2011170","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2011170.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T06:11:17Z","timestamp":1650348677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2011170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":86,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFgt2011170"],"URL":"https:\/\/doi.org\/10.1038\/gt.2011.170","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"11 July 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}